Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer
Clinical trial NCT04526470 · UNKNOWN
Trial details
- NCT number
- NCT04526470
- Sponsor
- Seoul National University Bundang Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2023-06-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.